Annual Interest Expense
$121.22 M
-$34.75 M-22.28%
31 December 2023
Summary:
Alnylam Pharmaceuticals annual interest expense is currently $121.22 million, with the most recent change of -$34.75 million (-22.28%) on 31 December 2023. During the last 3 years, it has risen by +$36.73 million (+43.46%). ALNY annual interest expense is now -22.28% below its all-time high of $155.97 million, reached on 31 December 2022.ALNY Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$34.38 M
+$1.12 M+3.36%
30 September 2024
Summary:
Alnylam Pharmaceuticals quarterly interest expense is currently $34.38 million, with the most recent change of +$1.12 million (+3.36%) on 30 September 2024. Over the past year, it has increased by +$3.48 million (+11.27%). ALNY quarterly interest expense is now -19.32% below its all-time high of $42.61 million, reached on 30 June 2022.ALNY Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$134.22 M
+$3.48 M+2.66%
30 September 2024
Summary:
Alnylam Pharmaceuticals TTM interest expense is currently $134.22 million, with the most recent change of +$3.48 million (+2.66%) on 30 September 2024. Over the past year, it has increased by +$14.43 million (+12.04%). ALNY TTM interest expense is now -17.59% below its all-time high of $162.87 million, reached on 30 September 2022.ALNY TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALNY Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.3% | +11.3% | +12.0% |
| 3 y3 years | +43.5% | -14.6% | -0.4% |
| 5 y5 years | +100.0% | +100.0% | +100.0% |
ALNY Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -22.3% | +43.5% | -19.3% | +18.7% | -17.6% | +12.0% |
| 5 y | 5 years | -22.3% | -19.3% | -17.6% | |||
| alltime | all time | -22.3% | -19.3% | -17.6% |
Alnylam Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $34.38 M(+3.4%) | $134.22 M(+2.7%) |
| June 2024 | - | $33.26 M(-5.7%) | $130.74 M(+2.5%) |
| Mar 2024 | - | $35.25 M(+12.5%) | $127.52 M(+5.2%) |
| Dec 2023 | $121.22 M(-22.3%) | $31.34 M(+1.4%) | $121.22 M(+1.2%) |
| Sept 2023 | - | $30.89 M(+2.9%) | $119.80 M(-7.8%) |
| June 2023 | - | $30.04 M(+3.7%) | $129.99 M(-8.8%) |
| Mar 2023 | - | $28.95 M(-3.2%) | $142.56 M(-8.6%) |
| Dec 2022 | $155.97 M(+9.1%) | $29.91 M(-27.2%) | $155.97 M(-4.2%) |
| Sept 2022 | - | $41.08 M(-3.6%) | $162.87 M(+0.5%) |
| June 2022 | - | $42.61 M(+0.6%) | $162.06 M(+6.0%) |
| Mar 2022 | - | $42.36 M(+15.1%) | $152.87 M(+6.9%) |
| Dec 2021 | $143.02 M | $36.82 M(-8.6%) | $143.02 M(+6.2%) |
| Sept 2021 | - | $40.27 M(+20.5%) | $134.72 M(+9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $33.42 M(+2.8%) | $123.18 M(+5.3%) |
| Mar 2021 | - | $32.52 M(+14.0%) | $117.01 M(+38.5%) |
| Dec 2020 | $84.50 M(>+9900.0%) | $28.52 M(-0.7%) | $84.50 M(+50.9%) |
| Sept 2020 | - | $28.73 M(+5.4%) | $55.98 M(+105.4%) |
| June 2020 | - | $27.25 M(>+9900.0%) | $27.25 M(>+9900.0%) |
| Mar 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2019 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2019 | - | $0.00 | $0.00 |
| Dec 2018 | $0.00(0.0%) | - | - |
| Dec 2009 | $0.00(-100.0%) | - | - |
| Dec 2008 | $872.00 K(-19.5%) | - | - |
| Dec 2007 | $1.08 M | - | - |
FAQ
- What is Alnylam Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual interest expense year-on-year change?
- What is Alnylam Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly interest expense year-on-year change?
- What is Alnylam Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals TTM interest expense year-on-year change?
What is Alnylam Pharmaceuticals annual interest expense?
The current annual interest expense of ALNY is $121.22 M
What is the all time high annual interest expense for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual interest expense is $155.97 M
What is Alnylam Pharmaceuticals annual interest expense year-on-year change?
Over the past year, ALNY annual interest expense has changed by -$34.75 M (-22.28%)
What is Alnylam Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of ALNY is $34.38 M
What is the all time high quarterly interest expense for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly interest expense is $42.61 M
What is Alnylam Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, ALNY quarterly interest expense has changed by +$3.48 M (+11.27%)
What is Alnylam Pharmaceuticals TTM interest expense?
The current TTM interest expense of ALNY is $134.22 M
What is the all time high TTM interest expense for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high TTM interest expense is $162.87 M
What is Alnylam Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, ALNY TTM interest expense has changed by +$14.43 M (+12.04%)